KA
Insider selling
Kristin Abate sold $2K of KPTI stock
Kristin Abate, Chief Accounting Officer of Karyopharm Therapeutics Inc. (KPTI), sold 4,788 shares of KPTI stock worth $2K, per an SEC Form 4 filed Oct 19, 2026.
It was an open-market sale.
The trade happened on Oct 16, 2026, 3 days before it was made public.
KPTI has moved -8.1% since the trade date, from $0.39 to $0.36 (Oct 20, 2026 close).
- Traded
- Oct 16, 2026
- Disclosed
- Oct 19, 2026
- Filing delay
- 3 days
- Price since
- -8.1%
- Role
- Chief Accounting Officer
- Source
- SEC Form 4
More KPTI insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.